CEP
GILD icon

Chicago Equity Partners’s Gilead Sciences GILD Stock Holding History

Chicago Equity Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$3.04M Sell
40,626
-3,615
-8% -$250K 0.31% 74
2019
Q4 		$2.88M Buy
44,241
+25,471
+136% +$1.66M 0.16% 178
2019
Q3 		$1.19M Sell
18,770
-10,933
-37% -$715K 0.06% 448
2019
Q2 		$2.01M Sell
29,703
-7,320
-20% -$482K 0.09% 326
2019
Q1 		$2.41M Sell
37,023
-61,355
-62% -$4.08M 0.09% 303
2018
Q4 		$6.15M Sell
98,378
-46,435
-32% -$3.25M 0.25% 111
2018
Q3 		$11.2M Sell
144,813
-12,225
-8% -$923K 0.33% 74
2018
Q2 		$11.1M Sell
157,038
-21,835
-12% -$1.54M 0.34% 67
2018
Q1 		$13.5M Sell
178,873
-12,560
-7% -$998K 0.43% 47
2017
Q4 		$13.7M Sell
191,433
-2,580
-1% -$196K 0.42% 55
2017
Q3 		$15.7M Sell
194,013
-60,910
-24% -$4.66M 0.5% 39
2017
Q2 		$18M Sell
254,923
-23,190
-8% -$1.54M 0.49% 45
2017
Q1 		$18.9M Sell
278,113
-100,485
-27% -$7.07M 0.54% 40
2016
Q4 		$27.1M Sell
378,598
-16,195
-4% -$1.2M 0.72% 31
2016
Q3 		$31.2M Sell
394,793
-61,865
-14% -$5.03M 0.86% 22
2016
Q2 		$38.1M Sell
456,658
-7,660
-2% -$680K 1.11% 13
2016
Q1 		$42.7M Sell
464,318
-122,695
-21% -$11.1M 1.24% 10
2015
Q4 		$59.4M Sell
587,013
-14,155
-2% -$1.47M 1.58% 7
2015
Q3 		$59M Sell
601,168
-19,847
-3% -$2.2M 1.65% 4
2015
Q2 		$72.7M Sell
621,015
-29,110
-4% -$3.18M 1.98% 5
2015
Q1 		$63.8M Sell
650,125
-78,485
-11% -$7.97M 1.7% 6
2014
Q4 		$68.7M Sell
728,610
-25,005
-3% -$2.59M 1.85% 7
2014
Q3 		$80.2M Sell
753,615
-82,455
-10% -$8.07M 2.11% 6
2014
Q2 		$69.3M Buy
836,070
+305,205
+57% +$23.8M 1.83% 5
2014
Q1 		$37.6M Buy
+530,865
New +$41.6M 1.04% 22

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Chicago Equity Partners's GILD Position: Q1 2020 in Review

Chicago Equity Partners reduced its Gilead Sciences (GILD) stake by 8.2% in Q1 2020, selling an estimated $250K and leaving 40,626 shares worth $3.04M. The position accounts for 0.31% of the portfolio, ranked #74.

Chicago Equity Partners first reported a position in GILD in Q1 2014 and has held it in 25 quarters since. The position peaked at $80.2M in Q3 2014. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • Chicago Equity Partners held 40,626 shares of Gilead Sciences worth $3.04M as of Q1 2020.
  • Chicago Equity Partners sold 3,615 Gilead Sciences shares in Q1 2020, an estimated $250K.
  • Gilead Sciences made up 0.31% of Chicago Equity Partners's portfolio in Q1 2020, its #74 holding.
  • Chicago Equity Partners first reported a position in Gilead Sciences in Q1 2014 and has held it in 25 quarters since.
  • Chicago Equity Partners's Gilead Sciences position peaked at $80.2M in Q3 2014.
  • 1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.